{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:17:01Z","timestamp":1787026621217,"version":"build-2736575974"},"reference-count":122,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS), has been estimated to infect around 40.8 million people globally. This virus can persist and thrive in the presence of antiretroviral therapy, which is a major obstacle to HIV eradication. Therefore, understanding host immunological factors that underlie HIV persistence and pathogenesis can lead to the development of immunotherapeutic interventions. Interleukin-32 (IL-32) is an orphan cytokine with multiple isoforms and a complex signal transduction pathway that transmits through non-specific receptors. It is a multifunctional cytokine with dual immunomodulatory roles in HIV infection. IL-32 possesses both antiviral and pathogenic properties. It can block viral entry to target cells and reverse transcriptase activity. Also, IL-32 can promote the reactivation of latent reservoirs. Paradoxically, IL-32 can inhibit HIV-specific immune response and facilitate HIV latency in CD4+ T cells. IL-32 has a central pathological role in HIV-related cardiovascular disease. Here in this review, we will discuss the biology of IL-32 and the current state-of-the-art knowledge of how IL-32 orchestrates diverse immune responses during HIV infection. In addition, the potential therapeutic strategies that could modulate IL-32 activity or expression will be highlighted.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1708955","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:32:03Z","timestamp":1764138723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Interleukin-32: a Pandora\u2019s box in human immunodeficiency virus infection"],"prefix":"10.3389","volume":"16","author":[{"given":"Abualgasim Elgaili","family":"Abdalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Manni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilal","family":"Elsaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Abosalif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman Ali Mohammed","family":"Alameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik Suliman","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"B1","unstructured":"Geneva, Switzerland\n          World Health Organization\n          Global hiv report\n          \n          2024"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000534","article-title":"Hiv subtype diversity worldwide","volume":"14","author":"Bbosa","year":"2019","journal-title":"Curr Opin HIV AIDS"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2019.0242","article-title":"The genetic diversity of hiv-1 quasispecies within primary infected individuals","volume":"36","author":"Liu","year":"2020","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.immuni.2023.01.030","article-title":"Hiv rapidly targets A diverse pool of cd4(+) T cells to establish productive and latent infections","volume":"56","author":"Gantner","year":"2023","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/v6041837","article-title":"Hiv-1 latency in monocytes\/macrophages","volume":"6","author":"Kumar","year":"2014","journal-title":"Viruses"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1203531","article-title":"Editorial: cd4+ T cells in hiv: A friend or A foe","volume":"14","author":"Govindaraj","year":"2023","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4MR0722-619R","article-title":"Role of macrophages in hiv pathogenesis and cure: nih perspectives","volume":"112","author":"Joseph","year":"2022","journal-title":"J Leukoc Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"155458","DOI":"10.1016\/j.cyto.2021.155458","article-title":"A primer on cytokines","volume":"145","author":"Chauhan","year":"2021","journal-title":"Cytokine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001858","article-title":"Irak1 inhibition blocks the hiv-1 rna mediated pro-inflammatory cytokine response from microglia","volume":"104","author":"Campbell","year":"2023","journal-title":"J Gen Virol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2012.05.005","article-title":"Cytokine production and dysregulation in hiv pathogenesis: lessons for development of therapeutics and vaccines","volume":"23","author":"Reuter","year":"2012","journal-title":"Cytokine Growth Factor Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.12.003","article-title":"Interleukin-32: A cytokine and inducer of tnfalpha","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1301-9","article-title":"Novel insights into the biology of interleukin-32","volume":"70","author":"Joosten","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.smim.2018.03.004","article-title":"Insights into the role of il-32 in cancer","volume":"38","author":"Sloot","year":"2018","journal-title":"Semin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"104011","DOI":"10.1016\/j.critrevonc.2023.104011","article-title":"Il-32 and its paradoxical role in neoplasia","volume":"186","author":"Hough","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13012","article-title":"The role of interleukin-32 in autoimmunity","volume":"93","author":"De Albuquerque","year":"2021","journal-title":"Scand J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4AB0219-071R","article-title":"Il-32 and its splice variants are associated with protection against mycobacterium tuberculosis infection and skewing of th1\/th17 cytokines","volume":"107","author":"Koeken","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"154793","DOI":"10.1016\/j.cyto.2019.154793","article-title":"Transgenic mice expressing human il-32 develop adipokine profiles resembling those of obesity-induced metabolic changes","volume":"125","author":"Damen","year":"2020","journal-title":"Cytokine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13071-017-2268-4","article-title":"Il-32\u03b3 Promotes the healing of murine cutaneous lesions caused by leishmania Braziliensis infection in contrast to leishmania amazonensis","volume":"10","author":"Gomes","year":"2017","journal-title":"Parasit Vectors"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.440115","article-title":"Inducible interleukin 32 (Il-32) exerts extensive antiviral function via selective stimulation of interferon \u039b1 (Ifn-\u039b1)","volume":"288","author":"Li","year":"2013","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"22902","DOI":"10.1038\/srep22902","article-title":"Proinflammatory isoforms of il-32 as novel and robust biomarkers for control failure in hiv-infected slow progressors","volume":"6","author":"El-Far","year":"2016","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200087","article-title":"Inhibitory and stimulatory effects of il-32 on hiv-1 infection","volume":"209","author":"Nasser","year":"2022","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"970\u2013978","DOI":"10.3390\/cells14070481","article-title":"Opposite roles of il-32\u03b1 Versus il-32\u03b2\/\u0393 Isoforms in promoting monocyte-derived osteoblast\/osteoclast differentiation and vascular calcification in people with hiv","volume":"14","author":"Ramani","year":"2025","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad576","article-title":"Il-32 drives the differentiation of cardiotropic cd4+ T cells carrying hiv dna in people with hiv","volume":"229","author":"Ramani","year":"2024","journal-title":"J Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","article-title":"Identification of A novel gene expressed in activated natural killer cells and T cells","volume":"148","author":"Dahl","year":"1992","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2014.01.013","article-title":"Interaction network mapping among il-32 isoforms","volume":"101","author":"Kang","year":"2014","journal-title":"Biochimie"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.664371","article-title":"Upregulated il-32 expression and reduced gut short chain fatty acid caproic acid in people living with hiv with subclinical atherosclerosis","volume":"12","author":"El-Far","year":"2021","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1140373","article-title":"Interleukin-32 as A biomarker in rheumatic diseases: A narrative review","volume":"14","author":"Kwon","year":"2023","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.837588","article-title":"Comparison of the seven interleukin-32 isoforms' Biological activities: il-32\u03b8 Possesses the most dominant biological activity","volume":"13","author":"Shim","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002972","article-title":"Overt il-32 isoform expression at intestinal level during hiv-1 infection is negatively regulated by il-17a","volume":"35","author":"Moreira Gabriel","year":"2021","journal-title":"Aids"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4110\/in.2019.19.e8","article-title":"Structural characteristics of seven il-32 variants","volume":"19","author":"Sohn","year":"2019","journal-title":"Immune Netw"},{"key":"B31","doi-asserted-by":"publisher","first-page":"8413768","DOI":"10.1155\/2016\/8413768","article-title":"Il-32: A novel pluripotent inflammatory interleukin, towards gastric inflammation, gastric cancer, and chronic rhino sinusitis","volume":"2016","author":"Khawar","year":"2016","journal-title":"Mediators Inflammation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.288290","article-title":"Interleukin 32 (Il-32) contains A typical \u03b1-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1","volume":"287","author":"Heinhuis","year":"2012","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.03.012","article-title":"Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of nf-\u03bab","volume":"48","author":"Pan","year":"2011","journal-title":"Mol Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1684\/ecn.2018.0407","article-title":"Interleukin-32 plays an essential role in human calcified aortic valve cells","volume":"29","author":"Tsai","year":"2018","journal-title":"Eur Cytokine Netw"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088270","article-title":"Elevated interleukin-32 expression is associated with helicobacter pylori-related gastritis","volume":"9","author":"Peng","year":"2014","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2012.763102","article-title":"Tlr-mediated induction of proinflammatory cytokine il-32 in corneal epithelium","volume":"38","author":"Zhang","year":"2013","journal-title":"Curr Eye Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24285","article-title":"Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis","volume":"53","author":"Moschen","year":"2011","journal-title":"Hepatology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902667","article-title":"Il-32: A host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection","volume":"185","author":"Li","year":"2010","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00637-12","article-title":"Role of interleukin-32 in helicobacter pylori-induced gastric inflammation","volume":"80","author":"Sakitani","year":"2012","journal-title":"Infect Immun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00535.2007","article-title":"Phosphatidylinositol 3-kinase\/akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts","volume":"294","author":"Nishida","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/art.24299","article-title":"Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the syk\/protein kinase cdelta\/jnk pathway in rheumatoid synovial fibroblasts","volume":"60","author":"Mun","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cyto.2010.09.002","article-title":"Native il-32 is released from intestinal epithelial cells via A non-classical secretory pathway as A membrane-associated protein","volume":"53","author":"Hasegawa","year":"2011","journal-title":"Cytokine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-081720-114505","article-title":"Mapk-activated protein kinases: servant or partner","volume":"91","author":"Ronkina","year":"2022","journal-title":"Annu Rev Biochem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713222","article-title":"Saturated fat-mediated upregulation of il-32 and ccl20 in hepatocytes contributes to higher expression of these fibrosis-driving molecules in masld","volume":"24","author":"Schilcher","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2650","article-title":"Nod2 triggers an interleukin-32-dependent human dendritic cell program in leprosy","volume":"18","author":"Schenk","year":"2012","journal-title":"Nat Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.805720","article-title":"Lipophosphoglycan from dermotropic new world leishmania upregulates interleukin-32 and proinflammatory cytokines through tlr4 and nod2 receptors","volume":"12","author":"Silveira","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1342641","article-title":"The regulation and potential role of interleukin-32 in tuberculous pleural effusion","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1437224","article-title":"Il-2 and tcr stimulation induce expression and secretion of il-32\u03b2 By human T cells","volume":"15","author":"Sanna","year":"2024","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2057837","DOI":"10.1080\/2162402X.2022.2057837","article-title":"Myeloma-derived il-32\u03b3 Induced pd-L1 expression in macrophages facilitates immune escape via the pfkfb3-jak1 axis","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1868-7083-4-20","article-title":"Genome-scale case-control analysis of cd4+ T-cell dna methylation in juvenile idiopathic arthritis reveals potential targets involved in disease","volume":"4","author":"Ellis","year":"2012","journal-title":"Clin Epigenet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13072-015-0037-1","article-title":"Ethnicity-specific epigenetic variation in na\u00efve cd4+ T cells and the susceptibility to autoimmunity","volume":"8","author":"Coit","year":"2015","journal-title":"Epigenet Chromatin"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014467","article-title":"Single-cell multiomics reveal divergent effects of dnmt3a- and tet2-mutant clonal hematopoiesis in inflammatory response","volume":"9","author":"Mohammed Ismail","year":"2025","journal-title":"Blood Adv"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.006255","article-title":"The proinflammatory cytokine tnf\u03b1 Induces dna demethylation-dependent and -independent activation of interleukin-32 expression","volume":"294","author":"Zhao","year":"2019","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.celrep.2019.08.004","article-title":"\u03b2-glucan-induced trained immunity protects against leishmania Braziliensis infection: A crucial role for il-32","volume":"28","author":"Dos Santos","year":"2019","journal-title":"Cell Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i19.2355","article-title":"Butyrate stimulates il-32alpha expression in human intestinal epithelial cell lines","volume":"16","author":"Kobori","year":"2010","journal-title":"World J Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1159\/000489367","article-title":"Histone deacetylases promote er stress induced epithelial mesenchymal transition in human lung epithelial cells","volume":"46","author":"Liu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/ioae118","article-title":"Il-32 regulates trophoblast invasion through mir-205-nf\u03bab-mmp2\/9 axis contributing to the pregnancy-induced hypertension\u2020","volume":"111","author":"Liu","year":"2024","journal-title":"Biol Reprod"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-024-01094-7","article-title":"Il-32\/nf\u03bab\/mir-205 loop sustains the high expression of il-32 and enhances the motility of cervical cancer cells","volume":"37","author":"Liu","year":"2024","journal-title":"Hum Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"E50203","DOI":"10.1371\/journal.pone.0050203","article-title":"Inhibition of pten gene expression by oncogenic mir-23b-3p in renal cancer","volume":"7","author":"Zaman","year":"2012","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030389","article-title":"Transcriptomic and functional evidence that mirna193a-3p inhibits lymphatic endothelial cell (Lec) and lec + Mcf-7 spheroid growth directly and by altering mcf-7 secretome","volume":"12","author":"Azzarito","year":"2023","journal-title":"Cells"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.44377","article-title":"Mir-19 regulates the expression of interferon-induced genes and mhc class I genes in human cancer cells","volume":"17","author":"Li","year":"2020","journal-title":"Int J Med Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1743-422X-10-51","article-title":"The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-mir-ul112-1","volume":"10","author":"Huang","year":"2013","journal-title":"Virol J"},{"key":"B63","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/CH-221624","article-title":"Lncrna hcg18 loaded by polymorphonuclear neutrophil-secreted exosomes aggravates sepsis acute lung injury by regulating macrophage polarization","volume":"85","author":"Zhu","year":"2023","journal-title":"Clin Hemorheol Microcirc"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1974808","article-title":"Identification of downstream targets and signaling pathways of long non-coding rna nr_002794 in human trophoblast cells","volume":"12","author":"Ma","year":"2021","journal-title":"Bioengineered"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0511206103","article-title":"Proteinase 3 is an il-32 binding protein","volume":"103","author":"Novick","year":"2006","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21611","article-title":"Interleukin-32\u03b1 Promotes the proliferation of multiple myeloma cells by inducing production of il-6 in bone marrow stromal cells","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"B67","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4049\/jimmunol.1202802","article-title":"Il-32 promotes angiogenesis","volume":"192","author":"Nold-Petry","year":"2014","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.09.015","article-title":"Il-32\u03b8 Downregulates ccl5 expression through its interaction with pkc\u03b4 And stat3","volume":"26","author":"Bak","year":"2014","journal-title":"Cell Signal"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.400911","article-title":"Intracellular interaction of interleukin (Il)-32\u03b1 With protein kinase C\u03f5 (Pkc\u03f5 ) and stat3 protein augments il-6 production in thp-1 promonocytic cells","volume":"287","author":"Kang","year":"2012","journal-title":"J Biol Chem"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081949","article-title":"Inhibition of il-13 and il-13r\u03b12 expression by il-32\u03b8 In human monocytic cells requires pkc\u03b4 And stat3 association","volume":"20","author":"Pham","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-022-02348-8","article-title":"Extracellular vesicle il-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via fak\/stat3 pathway","volume":"41","author":"Sun","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1186\/ar410","article-title":"Proteinase-3 as the major autoantigen of C-anca is strongly expressed in lung tissue of patients with wegener's granulomatosis","volume":"4","author":"Brockmann","year":"2002","journal-title":"Arthritis Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.698639","article-title":"Proteinase 3 is A phosphatidylserine-binding protein that affects the production and function of microvesicles","volume":"291","author":"Martin","year":"2016","journal-title":"J Biol Chem"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12026-024-09578-2","article-title":"Versatile roles for neutrophil proteinase 3 in hematopoiesis and inflammation","volume":"73","author":"Zhu","year":"2024","journal-title":"Immunol Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1038\/srep02960","article-title":"Il-32-par2 axis is an innate immunity sensor providing alternative signaling for lps-trif axis","volume":"3","author":"Nakayama","year":"2013","journal-title":"Sci Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.06.029","article-title":"Il-32\u03b8 Negatively regulates il-1\u03b2 Production through its interaction with pkc\u03b4 and the inhibition of pu.1 phosphorylation","volume":"588","author":"Kim","year":"2014","journal-title":"FEBS Lett"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0813452","article-title":"Molecular mechanisms regulating the synergism between il-32\u03b3 and nod for the activation of eosinophils","volume":"95","author":"Wong","year":"2014","journal-title":"J Leukoc Biol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00636-5","article-title":"Placenta-derived il-32\u03b2 activates neutrophils to promote preeclampsia development","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/cells13030212","article-title":"Integrins in health and disease-suitable targets for treatment","volume":"13","author":"Klaus","year":"2024","journal-title":"Cells"},{"key":"B80","doi-asserted-by":"publisher","first-page":"11675","DOI":"10.1038\/ncomms11675","article-title":"Rational design of a protein that binds integrin \u03b1v\u03b23 outside the ligand binding site","volume":"7","author":"Turaga","year":"2016","journal-title":"Nat Commun"},{"key":"B81","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12931-018-0863-3","article-title":"Il-32\u03b3 Attenuates airway fibrosis by modulating the integrin-fak signaling pathway in fibroblasts","volume":"19","author":"Hong","year":"2018","journal-title":"Respir Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.10.015","article-title":"Cancer-associated fibroblast (Caf)-derived il32 promotes breast cancer cell invasion and metastasis via integrin \u03b23-P38 mapk signalling","volume":"442","author":"Wen","year":"2019","journal-title":"Cancer Lett"},{"key":"B83","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41419-019-1737-4","article-title":"Il-32\u03b3 suppresses lung cancer stem cell growth via inhibition of itgav-mediated stat5 pathway","volume":"10","author":"Lee","year":"2019","journal-title":"Cell Death Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1160301","article-title":"Human il-32\u03b8a94v mutant attenuates monocyte-endothelial adhesion by suppressing the expression of icam-1 and vcam-1 via binding to cell surface receptor integrin \u03b1v\u03b23 and \u03b1v\u03b26 in tnf-\u03b1-stimulated huvecs","volume":"14","author":"Park","year":"2023","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1038\/s41598-025-95222-4","article-title":"Author correction: mutated il-32\u03b8 (A94v) inhibits cox2, gm-csf and cyp1a1 through ahr\/arnt and mapks\/nf-\u03bab\/ap-1 in keratinocytes exposed to pm(10)","volume":"15","author":"Kim","year":"2025","journal-title":"Sci Rep"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.704853","article-title":"Interleukin 32 promotes foxp3(+) treg cell development and cd8(+) T cell function in human esophageal squamous cell carcinoma microenvironment","volume":"9","author":"Han","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2022.2138430","article-title":"Impact of interleukin-32\u03b1 On T helper cell-related cytokines, transcription factors, and proliferation in patients with type 2 diabetes mellitus","volume":"45","author":"Borzouei","year":"2023","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002185","article-title":"Upregulation of il-32 isoforms in virologically suppressed hiv-infected individuals: potential role in persistent inflammation and transcription from stable hiv-1 reservoirs","volume":"82","author":"Zaidan","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2008.01.007","article-title":"Increased level of il-32 during human immunodeficiency virus infection suppresses hiv replication","volume":"117","author":"Rasool","year":"2008","journal-title":"Immunol Lett"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1701729","article-title":"Allele-specific long-distance regulation dictates il-32 isoform switching and mediates susceptibility to hiv-1","volume":"4","author":"Palstra","year":"2018","journal-title":"Sci Adv"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.1.557","article-title":"Endogenous il-32 controls cytokine and hiv-1 production","volume":"181","author":"Nold","year":"2008","journal-title":"J Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-014-0329-2","article-title":"Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically hiv-1-infected patients","volume":"203","author":"Monteleone","year":"2014","journal-title":"Med Microbiol Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302732","article-title":"M-csf inhibits anti-hiv-1 activity of il-32, but they enhance M2-like phenotypes of macrophages","volume":"192","author":"Osman","year":"2014","journal-title":"J Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/v17040514","article-title":"Design and characterization of inhibitors of cell-mediated degradation of apobec3g that decrease hiv-1 infectivity","volume":"17","author":"Sawyer","year":"2025","journal-title":"Viruses"},{"key":"B95","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbrc.2014.11.058","article-title":"Structural insight into the assembly of human anti-hiv dynamin-like protein mxb\/mx2","volume":"456","author":"Xu","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078146","article-title":"Distinct tryptophan catabolism and th17\/treg balance in hiv progressors and elite controllers","volume":"8","author":"Jenabian","year":"2013","journal-title":"PloS One"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu115","article-title":"The kynurenine pathway of tryptophan catabolism, cd4+ T-cell recovery, and mortality among hiv-infected Ugandans initiating antiretroviral therapy","volume":"210","author":"Byakwaga","year":"2014","journal-title":"J Infect Dis"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv037","article-title":"Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early hiv infection","volume":"212","author":"Jenabian","year":"2015","journal-title":"J Infect Dis"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100594","article-title":"Hiv-mediated phosphatidylinositol 3-kinase\/serine-threonine kinase activation in apcs leads to programmed death-1 ligand upregulation and suppression of hiv-specific cd8 T cells","volume":"187","author":"Muthumani","year":"2011","journal-title":"J Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100277","article-title":"The immunosuppressive role of il-32 in lymphatic tissue during hiv-1 infection","volume":"186","author":"Smith","year":"2011","journal-title":"J Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"101438","DOI":"10.1016\/j.smim.2020.101438","article-title":"Hiv persistence in subsets of cd4+ T cells: 50 shades of reservoirs","volume":"51","author":"Fromentin","year":"2021","journal-title":"Semin Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.720697","article-title":"The effect of jak1\/2 inhibitors on HIV reservoir using primary lymphoid cell model of hiv latency","volume":"12","author":"De Armas","year":"2021","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw612","article-title":"Role of interleukin 32 in human immunodeficiency virus reactivation and its link to human immunodeficiency virus-herpes simplex virus coinfection","volume":"215","author":"Mesquita","year":"2017","journal-title":"J Infect Dis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.673061","article-title":"Loss of cd96 expression as A marker of hiv-specific cd8(+) T-cell differentiation and dysfunction","volume":"12","author":"Bunet","year":"2021","journal-title":"Front Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.01.012","article-title":"Increased expression of il-32 correlates with ifn-\u0393, th1 and tc1 in virologically suppressed hiv-1-infected patients","volume":"120","author":"Santinelli","year":"2019","journal-title":"Cytokine"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30036-9","article-title":"Hiv and cardiovascular disease","volume":"7","author":"So-Armah","year":"2020","journal-title":"Lancet HIV"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002746","article-title":"Brief report: subclinical carotid artery atherosclerosis is associated with increased expression of peripheral blood il-32 isoforms among women living with hiv","volume":"88","author":"El-Far","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B108","doi-asserted-by":"publisher","first-page":"E27","DOI":"10.4110\/in.2024.24.e27","article-title":"Recombinant human il-32\u03b8 Induces polarization into M1-like macrophage in human monocytic cells","volume":"24","author":"Park","year":"2024","journal-title":"Immune Netw"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/v15030700","article-title":"Differential impact of il-32 isoforms on the functions of coronary artery endothelial cells: A potential link with arterial stiffness and atherosclerosis","volume":"15","author":"Bunet","year":"2023","journal-title":"Viruses"},{"key":"B110","doi-asserted-by":"publisher","first-page":"149863","DOI":"10.1016\/j.bbrc.2024.149863","article-title":"The role of macrophage polarization in vascular calcification","volume":"710","author":"Li","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.02.015","article-title":"Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the bayer chemical research laboratory","volume":"27","author":"Beck","year":"2022","journal-title":"Drug Discov Today"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092696","article-title":"Novel small molecule inhibitors targeting the il-6\/stat3 pathway or il-1\u03b2","volume":"27","author":"Yoo","year":"2022","journal-title":"Molecules"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00485","article-title":"Discovery of a small-molecule inhibitor of interleukin 15: pharmacophore-based virtual screening and hit optimization","volume":"60","author":"Qu\u00e9m\u00e9ner","year":"2017","journal-title":"J Med Chem"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29030585","article-title":"The pharmaceutical industry in 2024: an analysis of the FDA drug approvals from the perspective of molecules","volume":"30","author":"De La Torre","year":"2025","journal-title":"Molecules"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/cimb44050127","article-title":"The treatment with interleukin 17 inhibitors and immune-mediated inflammatory diseases","volume":"44","author":"\u021aiburc\u0103","year":"2022","journal-title":"Curr Issues Mol Biol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03043-1","article-title":"Il-6 inhibition with clazakizumab in patients receiving maintenance dialysis: A randomized phase 2b trial","volume":"30","author":"Chertow","year":"2024","journal-title":"Nat Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083456","article-title":"Recent update on sirna therapeutics","volume":"26","author":"Ebenezer","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43856-023-00419-1","article-title":"Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders","volume":"4","author":"Lauffer","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2009.12.021","article-title":"Identification of known drugs that act as inhibitors of nf-kappab signaling and their mechanism of action","volume":"79","author":"Miller","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145164","article-title":"Small molecule nf-\u03bab pathway inhibitors in clinic","volume":"21","author":"Ramadass","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2013.10.019","article-title":"Interleukin-32\u03b4 Interacts with il-32\u03b2 And inhibits il-32\u03b2-mediated il-10 production","volume":"587","author":"Kang","year":"2013","journal-title":"FEBS Lett"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1992","article-title":"Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and chinese rhesus macaques","volume":"29","author":"Yan","year":"2011","journal-title":"Nat Biotechnol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1708955\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:32:06Z","timestamp":1764138726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1708955\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":122,"alternative-id":["10.3389\/fimmu.2025.1708955"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1708955","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"article-number":"1708955"}}